Papers
7
Total Citations
158
H-Index
5
About
Dr. Izak Faiena is a urologic surgeon and researcher whose work centers on optimizing surgical outcomes for patients with urologic malignancies, particularly prostate, bladder, and upper tract cancers. His research is distinguished by a focus on comparative effectiveness, examining how surgical approach—open, laparoscopic, or robotic—impacts oncologic and cost outcomes. Dr. Faiena’s most cited study (64 citations) demonstrated that surgical approach influences lymph node dissection yield and survival in upper tract urothelial carcinoma, a key contribution to surgical quality. He has also advanced the use of multiparametric MRI in prostate cancer, showing that PI-RADS v2 scores can predict oncologic outcomes in Gleason 3+4 disease (27 citations). His work on cost variations in robotic versus open prostatectomy (30 citations) and his review of controversies in robotic cystectomy (19 citations) have informed evidence-based surgical decision-making. With additional publications on adrenalectomy and enhanced recovery after cystectomy, Dr. Faiena’s research consistently bridges surgical technique, patient outcomes, and health policy, making him a valuable voice in the evolution of minimally invasive urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4Controversies in Robotics: Open Versus Robotic Radical Cystectomy19 citations · 2015
- 5
- 6
- 7Laparoscopic partial nephrectomy: state of the art review3 citations · 2014